Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis C
  Free Subscription

Articles published in
J Med Virol
    May 2026
  1. CHANG SS, Liu CH, Chan SY, Lin LT, et al
    Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post-DAA Management.
    J Med Virol. 2026;98:e70952.
    >> Share

  2. YAN L, Wubuliaishan M, Kou X, Tuerxun M, et al
    Efficacy and Safety of 12-Week Coblopasvir/Sofosbuvir Regimen for Hepatitis C in Northwest China: A Multi-Center Prospective Study.
    J Med Virol. 2026;98:e70978.
    >> Share

  3. ELBASIONY M, Abdel-Samiee M, Zalata K, Hassan A, et al
    Influence of Schistosomiasis on Fibrosis Evolution After Interferon-Induced SVR in Chronic HCV Over a 12-Year Biopsy-Based Study.
    J Med Virol. 2026;98:e70974.
    >> Share

    April 2026
  4. AL-SHUAILI HH, Al-Busafi SA, Al Busafi SS, Naamani ZA, et al
    Impact of Hepatitis B Exposure and/or HIV Co-Infection on Clinical Outcomes in Chronic Hepatitis C Patients in Oman: An Ambidirectional Cohort Study.
    J Med Virol. 2026;98:e70903.
    >> Share

    March 2026
  5. TOYODA H, Nozaki A, Hiraoka A, Itobayashi E, et al
    Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection.
    J Med Virol. 2026;98:e70865.
    >> Share

    January 2026
  6. CHANG YP, Chen YC, Lee JY, Chen CY, et al
    Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic Fibrosis.
    J Med Virol. 2026;98:e70797.
    >> Share

    November 2025
  7. ALKILANY LF, Alkilany SF, Gaber N, Farrag A, et al
    "Exploring Hepatitis C as a Relapse Risk Factor in Pediatric Acute Lymphoblastic Leukemia: A Study From a Resource-Limited Egyptian Setting".
    J Med Virol. 2025;97:e70683.
    >> Share

  8. NABIH OS, Samiee MA, Tahoon MA, Abozeid E, et al
    Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV-Induced Cirrhosis.
    J Med Virol. 2025;97:e70686.
    >> Share

  9. FAZLI P, Bakhtiari S, Jalilian FA, Teimoori A, et al
    Clinical and Immunological Impact of Occult Hepatitis B Virus Infection Among HIV-Infected Patients With and Without HCV Co-Infection in Iran: A Cross-Sectional Analysis.
    J Med Virol. 2025;97:e70715.
    >> Share

  10. HUANG R, Ji F, Jiang Y, Li S, et al
    Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial.
    J Med Virol. 2025;97:e70709.
    >> Share

  11. ABDEL-SAMIEE M, Aburaia G, Abdelsameea E, Fathy S, et al
    Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin.
    J Med Virol. 2025;97:e70692.
    >> Share

    October 2025
  12. SHI S, Zhai M, Wu B, Sun W, et al
    Mitochondrial Disruption in Viral-Mediated Neuronal Injury: A Mechanistic Perspective.
    J Med Virol. 2025;97:e70626.
    >> Share

  13. YUNIHASTUTI E, Ophinni Y, Sari V, Adli I, et al
    Longitudinal Changes in Immune Biomarkers Following Direct-Acting Antiviral Therapy in HIV/HCV-Coinfected Individuals in Indonesia.
    J Med Virol. 2025;97:e70627.
    >> Share

    July 2025
  14. PANG X, He Q, Huang J, Tang K, et al
    Epidemiological Trends and CD4+T Cell Recovery in HIV-1 Patients With HCV/HBV Co-Infection: A Retrospective Cohort Study in Southwest China (2003-2024).
    J Med Virol. 2025;97:e70465.
    >> Share

    June 2025
  15. MISRA G, Gupta M, Singhal R, Qaisar S, et al
    Strategic Approach to Enhancing Diagnostic Precision: Optimizing Panel Size for HBV and HCV Viral Load Monitoring Kits.
    J Med Virol. 2025;97:e70437.
    >> Share

    March 2025
  16. JIN Q, Zhou M, Sun M, Ning B, et al
    Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021 Data.
    J Med Virol. 2025;97:e70283.
    >> Share

  17. PONNUVEL S, Ali H, Prakash A, John Steve R, et al
    Superior Performance of Newly Developed Alinity Anti-HCV Next Assay in the Diagnosis of HCV Infection.
    J Med Virol. 2025;97:e70307.
    >> Share

    February 2025
  18. LUZ E, Marques M, Arriaga MB, Campos LM, et al
    Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.
    J Med Virol. 2025;97:e70186.
    >> Share

  19. ARSLAN N, Reuter B, Buech J, Lengauer T, et al
    Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning Methods.
    J Med Virol. 2025;97:e70169.
    >> Share

    December 2024
  20. KAMBOJ S, Kumar M
    Global Origin and Spatiotemporal Spread of Hepatitis C Virus Epidemic Genotypes/Subtypes: A Complete Genome-Based Phylodynamic and Phylogeographic Analyses.
    J Med Virol. 2024;96:e70123.
    >> Share

    November 2024
  21. CHU D, Oh YH, Sung H, Ko DH, et al
    Simple, direct amplification of RNA-containing paper discs for diagnosing the hepatitis C virus.
    J Med Virol. 2024;96:e29919.
    >> Share

    October 2024
  22. TREVINO-NAKOURA A, Sepulveda-Crespo D, Bellon JM, Codina H, et al
    Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e70018.
    >> Share

    September 2024
  23. RZYMSKI P, Jibril AT, Rahmah L, Abarikwu SO, et al
    Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.
    J Med Virol. 2024;96:e29900.
    >> Share

    August 2024
  24. SAKR AA, Mohamed AA, Ahmed AE, Abdelhaleem AA, et al
    Biochemical implication of acetylcholine, histamine, IL-18, and interferon-alpha as diagnostic biomarkers in hepatitis C virus, coronavirus disease 2019, and dual hepatitis C virus-coronavirus disease 2019 patients.
    J Med Virol. 2024;96:e29857.
    >> Share

    July 2024
  25. LI Y, Zeng T, Huang P, Tan W, et al
    Investigating the role of killer cell immunoglobulin-like receptors and human leukocyte antigen genetic variants in hepatitis C virus infection.
    J Med Virol. 2024;96:e29776.
    >> Share

  26. CASTRO V, Calvo G, Oliveros JC, Perez-Del-Pulgar S, et al
    Hepatitis C virus-induced differential transcriptional traits in host cells after persistent infection elimination by direct-acting antivirals in cell culture.
    J Med Virol. 2024;96:e29787.
    >> Share

    June 2024
  27. GUO JW, Ho HY, Dai CY, Chen YH, et al
    Single-tube, single-strip lateral flow assays utilizing loop-mediated isothermal amplification for simultaneous hepatitis B and C viral detection.
    J Med Virol. 2024;96:e29721.
    >> Share

    May 2024
  28. LIU CH, Chang YP, Lee JY, Chen CY, et al
    Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
    J Med Virol. 2024;96:e29675.
    >> Share

  29. CHANG YP, Huang CB, Su TH, Liu CJ, et al
    Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.
    J Med Virol. 2024;96:e29686.
    >> Share

    April 2024

  30. Retraction: "Small Interfering RNA Effectively Inhibits Protein Expression and Negative Strand RNA Synthesis From a Full-Length Hepatitis C Virus Clone".
    J Med Virol. 2024;96:e29574.
    >> Share

    March 2024
  31. CHEN X, Dong S, Shi Y, Wu Z, et al
    Biosensor-based multiple cross displacement amplification platform for visual and rapid identification of hepatitis C virus.
    J Med Virol. 2024;96:e29481.
    >> Share

  32. MIUMA S, Miyaaki H, Ichikawa T, Matsuzaki T, et al
    Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.
    J Med Virol. 2024;96:e29432.
    >> Share

    February 2024
  33. CHEN B, Xu B, Cui HY, Ma ZH, et al
    Comparison of effectiveness and cost of different HCV testing strategies in high-risk populations in China.
    J Med Virol. 2024;96:e29433.
    >> Share

  34. LIU W, Li L, Yin M, Cao C, et al
    High-speed centrifugation rather than Lipoclear reagent can be used for removing the interference of lipemia on serological tests of infectious diseases: AIDS, hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle immunoassay.
    J Med Virol. 2024;96:e29385.
    >> Share

  35. LIU Y, Kim ES, Guo H
    Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures.
    J Med Virol. 2024;96:e29485.
    >> Share

    January 2024
  36. LI M, Wei Z, Su J, Wu X, et al
    Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China.
    J Med Virol. 2024;96:e29405.
    >> Share

  37. ADHIKARI A, Abayasingam A, Brasher NA, Kim HN, et al
    Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes.
    J Med Virol. 2024;96:e29381.
    >> Share

    December 2023
  38. ABDEL-SAMIEE M, Youssef MI, Elghamry F, Bazeed M, et al
    A multicentric and nationwide predictive study role of T cell sub-population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients.
    J Med Virol. 2023;95:e29248.
    >> Share

  39. NGARI JW, Leumi S, Han L, Liu C, et al
    Identification and characterization of Sofosbuvir-resistant mutations of hepatitis C virus genotype 3a replicon.
    J Med Virol. 2023;95:e29290.
    >> Share

    September 2023
  40. PENG X, Shi Y, Zhang B, Xu C, et al
    Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma.
    J Med Virol. 2023;95:e29084.
    >> Share

  41. LIU C, Guo M, Han L, Lu J, et al
    Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance.
    J Med Virol. 2023;95:e29103.
    >> Share

    August 2023
  42. ADACHI E, Saito M, Kikuchi T, Ikeuchi K, et al
    Incidence of sexually transmitted hepatitis C virus infection among men who have sex with men in Japan from 2009 to 2023.
    J Med Virol. 2023;95:e29039.
    >> Share

    July 2023
  43. LARA-AGUILAR V, Crespo-Bermejo C, Llamas-Adan M, Grande-Garcia S, et al
    HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART.
    J Med Virol. 2023;95:e28955.
    >> Share

  44. QU Y, Wang W, Xiao MZX, Zheng Y, et al
    The interplay between lipid droplets and virus infection.
    J Med Virol. 2023;95:e28967.
    >> Share

    March 2023
  45. WU B, Tobe RG, Yan M, Lin H, et al
    Trends of Global Burden Related to HBV and HCV from 1990 to 2019: An Age-Period-Cohort Analysis.
    J Med Virol. 2023 Mar 11. doi: 10.1002/jmv.28663.
    >> Share

  46. PISATURO M, Alessio L, Starace M, Macera M, et al
    CHARACTERIZATION OF HEPATITIS VIRUS CO-INFECTIONS IN A COHORT OF IMMIGRANTS LIVING IN SOUTHERN ITALY.
    J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28665.
    >> Share

  47. FENG Z, Huang P, Zhang J, Xia X, et al
    KIR2DL4/HLA-G polymorphisms were associated with HCV infection susceptibility among Chinese high-risk population.
    J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28645.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016